Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Jerome Whalen, M.D.

Co-Author

This page shows the publications co-authored by Michael Whalen and Rebekah Mannix.
Connection Strength

3.261
  1. Genetic influences and neuropathological sequelae of repetitive brain injury. Reply. Ann Neurol. 2014 Apr; 75(4):618.
    View in: PubMed
    Score: 0.572
  2. Clinical correlates in an experimental model of repetitive mild brain injury. Ann Neurol. 2013 Jul; 74(1):65-75.
    View in: PubMed
    Score: 0.546
  3. Beneficial effect of amyloid beta after controlled cortical impact. Brain Inj. 2013 Jun; 27(6):743-8.
    View in: PubMed
    Score: 0.534
  4. Traumatic brain injury, microglia, and Beta amyloid. Int J Alzheimers Dis. 2012; 2012:608732.
    View in: PubMed
    Score: 0.502
  5. Detrimental effect of genetic inhibition of B-site APP-cleaving enzyme 1 on functional outcome after controlled cortical impact in young adult mice. J Neurotrauma. 2011 Sep; 28(9):1855-61.
    View in: PubMed
    Score: 0.478
  6. Age-dependent effect of apolipoprotein E4 on functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2011 Jan; 31(1):351-61.
    View in: PubMed
    Score: 0.441
  7. Increasing recovery time between injuries improves cognitive outcome after repetitive mild concussive brain injuries in mice. Neurosurgery. 2012 Oct; 71(4):885-91.
    View in: PubMed
    Score: 0.129
  8. Persistent CO2 reactivity deficits are associated with neurological dysfunction up to one year after repetitive mild closed head injury in adolescent mice. J Cereb Blood Flow Metab. 2021 12; 41(12):3260-3272.
    View in: PubMed
    Score: 0.059
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.